Professional
Added to YB: 2026-03-20
Pitch date: 2026-01-30
HTFL [bullish]
HeartFlow, Inc.
-12.5%
current return
Author Info
No bio for this author
Company Info
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide.
Market Cap
$2.2B
Pitch Price
$29.59
Price Target
N/A
Dividend
N/A
EV/EBITDA
-35.82
P/E
-8.03
EV/Sales
11.44
Sector
Health Care Technology
Category
growth
Baron Opportunity Fund New Position: Heartflow, Inc.
HTFL (new position): AI-powered heart disease diagnostic w/ minimally invasive blockage detection, reducing false positives/negatives vs standard care. 110M image repository built over 10yrs = strong moat. 99% insurance coverage, FDA approved, 600+ peer studies. Low single-digit market penetration. Asset-light model w/ margin expansion as AI scales. New high-margin plaque analysis product launching on same backbone.
Read full article (1 min)